Menu

Diacomit

SKU:{{ product.sku }}
Model: {{ product.model }}
weight: {{ product.weight }} product.

{{ variable.name }}

{{ value.name }}

Stiripentol is a drug specially used to treat epilepsy. It mainly exerts its effect through a dual mechanism of action.

Drug name

Common name:Stiripentol (Stiripentol)

Trade name:< /b>Diacomit

Other names:DIACOMIT capsule/oral suspension

Indications

For the treatment of epileptic seizures in patients with Dravet syndrome 2 years of age and older (needs to be used in combination with clobazam). There are no clinical data to support the use of monotherapy in Dravet syndrome.

Specifications and properties

Capsules:

250mg: No. 2 pink capsule, printed with "Diacomit" and "250mg"

500 mg: No. 0 white capsules, printed with "Diacomit" and "500mg"

Oral suspension:

250mg/pack or 500mg/pack with light pink fruit Flavored powder

Main ingredients

Active ingredient: stiripentol

Excipients: capsules contain gelatin, magnesium stearate, etc.; suspension contains aspartame (contains phenylalanine)

p>

Usage and Dosage

Standard dose:50mg/kg/day, taken in 2-3 times (maximum daily dose 3000mg)

Dosage method:< /b>

Capsules: swallow whole, with a glass of water during meals

Suspension: mix with 100mL of water and take immediately, then add 25mL of water to rinse

Dose adjustment

h2>

1. Missed dose: Take the dose immediately, skip if it is close to the next dose time

2. Vomiting: No need to take the next dose, take the next dose as originally planned

< b>3. Withdrawal of medication:Need to gradually reduce the dose (sudden withdrawal of medication may induce status epilepticus)

Precautions for medication

1. Taking time:Must be taken with meals to improve High absorption

2. Special handling:

Capsules cannot be broken or chewed

The suspension must be prepared for immediate use and must not be stored

3. Monitoring requirements :Check the blood routine before taking the drug and every 6 months

Using the drug in special groups

Pregnant women: It may cause fetal malformations, so the pros and cons need to be weighed (Pregnancy Registration No. 1-888-2 33-2334)

Lactation period:No relevant data, it is recommended to suspend breastfeeding

Children:Safety under 2 years old has not been established

Liver Renal insufficiency:Not recommended for moderate to severe patients

Adverse reactions

Common (≥10%): Drowsiness (67%), decreased appetite (45%), coma Disorders (27%), weight loss (27%)

Serious adverse reactions: Neutropenia (13%), thrombocytopenia (13%), QT interval prolongation

Contraindications

There are no absolute contraindications, but suspensions (containing phenylalanine) are contraindicated in patients with phenylketonuria

Drug interactions

1. Increase the concentration: Make chlorine The concentration of Bazam and its metabolites increases 2-5 times (needs to reduce the dosage by 25%)

2. Contraindicated combinations: Strong CYP1A2/CYP3A4 inducers (such as rifampicin)

< b>3. Use with caution:CNS inhibitors (increased drowsiness)

Storage method

1. Temperature:20-25℃ (short-term storage at 15-30℃ is allowed) )

2. Environment: Store in original packaging, protected from light and moisture

3. Period: Do not store for a long time after opening

Manufacturer

French BIOCODEX company (1avenueBlaisePascal, 60000BEAUVAIS)